In 2022, Mounjaro made a splash in the medical world with its approval for the treatment of type 2 diabetes. But the exciting news doesn’t stop there – clinical trials have revealed that this innovative drug can also lead to significant weight loss, with participants losing over 20% of their body weight. Impressed by these impressive results, regulators have given Mounjaro the fast-track treatment, accelerating the review process for its use in the treatment of obesity.
In May of this year, the US Food and Drug Administration (FDA) granted its stamp of approval to tirzepatide, marketed as Mounjaro by Eli Lilly & Co., for the treatment of type 2 diabetes. But this medication may have an even bigger impact on the weight loss industry. The SURMOUNT-1 clinical trial, which administered a 15mg dose of tirzepatide to participants, resulted in a whopping 22.5% reduction in body weight.
It’s no surprise, then, that the FDA has given tirzepatide the coveted “fast track” designation for its review as a treatment for obesity. Lilly will be using data from the SURMOUNT-1 trial and the ongoing SURMOUNT-2 trial, which is studying the effects of tirzepatide in individuals with type 2 diabetes and excess weight or obesity, to support this designation.
The ongoing SURMOUNT-2 trial, set to be completed in April 2023, is investigating the use of tirzepatide as a treatment for individuals with type 2 diabetes and excess weight or obesity. Fortunately, the FDA’s fast-track designation for tirzepatide allows for the rolling submission of trial data, meaning the agency can review the information as it becomes available rather than waiting for the trial to conclude. This expedited review process could lead to a potential approval date sooner than expected.
The FDA grants fast-track designations to medications that have the potential to address a serious unmet medical need. With the increasing rates of adult and childhood obesity and the limited options for medical treatment, tirzepatide could be a groundbreaking solution in the fight against the obesity epidemic. In comparison to tirzepatide’s impressive 22.5% reduction in body weight, the current leading glucose-lowering medication for weight management, Wegovy (semaglutide), only resulted in a 14.9% reduction. Tirzepatide’s potential as a powerful weight-loss tool is clear.
FAQs
What is Mounjaro?
Mounjaro is a prescription medication that is approved for the treatment of type 2 diabetes. It is a brand name for the drug tirzepatide, which is made by Eli Lilly & Co.
How does Mounjaro work?
Mounjaro works by helping the body produce insulin, a hormone that regulates blood sugar levels. It is taken as a once-daily injection and can be used in combination with other diabetes medications.
Can Mounjaro be used for weight loss?
Mounjaro has shown promising results in clinical trials as a weight loss aid. Participants in the SURMOUNT-1 trial experienced a 22.5% reduction in body weight when taking a 15mg dose of the drug. However, Mounjaro is currently only approved for the treatment of type 2 diabetes, and further clinical trials are needed to determine its safety and effectiveness as a weight loss medication.
Is Mounjaro safe to use for weight loss?
Mounjaro has not yet been approved by the US Food and Drug Administration (FDA) for the treatment of obesity. It is important to speak with a healthcare provider about the potential risks and benefits of using Mounjaro or any other medication for weight loss.
What are the side effects of Mounjaro?
Common side effects of Mounjaro may include nausea, diarrhea, and stomach pain. More serious side effects may include pancreatitis (inflammation of the pancreas) and thyroid cancer. It is important to report any side effects to a healthcare provider.
How can I get Mounjaro?
Mounjaro is a prescription medication and can only be obtained with a valid prescription from a healthcare provider. It is important to follow the dosage and usage instructions provided by a healthcare provider.
Is Metermine good for weight loss?
Metermine is a brand name for the drug phentermine, which is a prescription medication used as an appetite suppressant to help with weight loss. It is typically used in combination with a reduced-calorie diet and exercise program. However, it is important to note that the safety and effectiveness of phentermine for weight loss have not been established in long-term use, and the drug may be associated with serious side effects. It is always important to speak with a healthcare provider about the potential risks and benefits of using any medication for weight loss.
Does Mounjaro speed up metabolism?
It is not known if Mounjaro (tirzepatide) has an effect on metabolism. Mounjaro is a prescription medication that is approved for the treatment of type 2 diabetes and works by helping the body produce insulin, a hormone that regulates blood sugar levels. It is not currently recommended for use as a weight loss medication, and further clinical trials are needed to determine its safety and effectiveness for this use.
What diet is best with Mounjaro?
As Mounjaro is currently only approved for the treatment of type 2 diabetes, it is not recommended for use as a weight loss medication. If you are using Mounjaro or any other medication for the treatment of type 2 diabetes, it is important to follow the dosage and usage instructions provided by a healthcare provider and to follow a healthy diet and exercise program as recommended by a healthcare provider.
What does Mounjaro do to your body?
Mounjaro is a prescription medication that is approved for the treatment of type 2 diabetes. It works by helping the body produce insulin, a hormone that regulates blood sugar levels. Mounjaro may also have other effects on the body, but this is not yet fully understood as further clinical trials are needed to determine its safety and effectiveness as a weight loss medication. It is always important to speak with a healthcare provider about the potential risks and benefits of using any medication.
